chartexchange

IDXG
INTERPACE BIOSCIENCES NEW
stockOTC

EODNov 18, 2026
5.435USD-9.417%(-0.565)2,310
Loading…
Loading…
Healthcare
Diagnostics & Research
CEO
Jack Stover
HQ
Parsippany, NJ, USA
Previous Close
$6.00
Beta
-0.23
52-Week High
$7.85 2026-08-26
52-Week Low
$0.81 2025-11-19
SMA 50
$4.27
SMA 200
$2.33
Avg. Vol 10D
1,221
Avg. Vol 30D
1,916
Avg. Vol 90D
4,312
Relative Vol
1.21
4.63M
887
Jan 15, 2020 · 1-for-10 (reverse)
IDXG Profile

advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.

IDXG Performance
PeriodPriceDateChangeBeta
1W6.202026-11-12-12.34%-5.375
1M5.002026-10-19+8.70%2.495
3M1.572026-08-19+246.18%0.705
6M1.802026-05-19+201.94%0.368
1Y0.862025-11-19+531.98%-0.227
2Y2.682024-11-19+103.18%—
5Y7.752021-11-19-29.87%-0.098
IDXG Stock Summary

INTERPACE BIOSCIENCES NEW (OTC:IDXG) stock price today is $5.44, and today's volume is 2,310. IDXG is down 9.417% today. The 30 day average volume is 1,916. IDXG market cap is $23.77M with 4.37M shares outstanding.